By Tulane University – MedicalXpress –
Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP)—a life-threatening fungal infection primarily affecting children and immunocompromised patients—more quickly and less invasively, according to a study published in the Journal of Clinical Investigation.
The highly accurate test detects RNA from live fungi in blood samples and throat swabs, eliminating the need for invasive bronchoscopy procedures currently used for diagnosis.
